In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) closed at $0.33 down -3.15% from its previous closing price of $0.34. In other words, the price has decreased by -$3.15 from its previous closing price. On the day, 2.28 million shares were traded. RVPH stock price reached its highest trading level at $0.338 during the session, while it also had its lowest trading level at $0.3251.
Ratios:
For a deeper understanding of Reviva Pharmaceuticals Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.39 and its Current Ratio is at 1.39. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Chardan Capital Markets on September 29, 2025, initiated with a Buy rating and assigned the stock a target price of $2.
On September 20, 2023, ROTH MKM started tracking the stock assigning a Buy rating and target price of $12.
On June 08, 2023, The Benchmark Company started tracking the stock assigning a Speculative Buy rating and target price of $17.The Benchmark Company initiated its Speculative Buy rating on June 08, 2023, with a $17 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RVPH now has a Market Capitalization of 38093080 and an Enterprise Value of 24325850.
Stock Price History:
The Beta on a monthly basis for RVPH is 0.06, which has changed by -0.8186813 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, RVPH has reached a high of $2.15, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is -31.14%, while the 200-Day Moving Average is calculated to be -42.44%.
Shares Statistics:
For the past three months, RVPH has traded an average of 6.48M shares per day and 3713290 over the past ten days. A total of 115.06M shares are outstanding, with a floating share count of 110.11M. Insiders hold about 4.30% of the company’s shares, while institutions hold 9.77% stake in the company. Shares short for RVPH as of 1767139200 were 21464180 with a Short Ratio of 3.31, compared to 1764288000 on 23151800. Therefore, it implies a Short% of Shares Outstanding of 21464180 and a Short% of Float of 19.18.
Earnings Estimates
The performance of Reviva Pharmaceuticals Holdings Inc (RVPH) in the stock market is under the watchful eye of 6.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.03 and low estimates of -$0.14.
Analysts are recommending an EPS of between -$0.28 and -$0.39 for the fiscal current year, implying an average EPS of -$0.33. EPS for the following year is -$0.27, with 7.0 analysts recommending between -$0.11 and -$0.85.
